Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Medication Guide

Dexamethasone

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference complete FDA data linked Rx required Liquid (Solution) Multiple FDA labelers Official label facts Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts
Reference refreshed
Jun 22, 2026, 10:41 a.m.

These are the reference facts Roxee uses on browse cards and quick facts.

FDA applications
FDA application data refreshed
Jun 22, 2026, 10:41 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
Jun 21, 2026, 5:14 a.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Reference facts: Source Roxee | Refreshed Jun 22, 2026, 10:41 AM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Jun 22, 2026, 10:40 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Jun 22, 2026, 10:41 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
Image coming soon
Dexamethasone

Dexamethasone

Drug type: Generic ingredient • Branded profile • FDA branded products available

Both Liquid (Solution) Rx required 100% reference complete

Species: Both

Manufacturer: Multiple FDA labelers

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Dexamethasone

In treatment of dogs as an anti-inflammatory agent. In treatment of cats as an anti-inflammatory agent. The drug is indicated for the treatment of primary bovine ketosis. Species commonly shown: Both, Dog, Horse, Not For Meat Production.

Generic name
Dexamethasone
Brand names
Zonometh Solution, Azium® Tablets 0.25 mg, Azium® Aqueous Suspension Veterinary, Azium® Solution
Manufacturer
Multiple FDA labelers
Species
Both, Dog, Horse, Cat
Dosage forms
Liquid (Solution), Tablet, Powder, Bolus
Prescription
Prescription required
Completeness
100%
Validation
Complete
Brand names
Zonometh Solution Azium® Tablets 0.25 mg Azium® Aqueous Suspension Veterinary Azium® Solution Azium® Powder Azium® Boluses 10 mg Azium® Oral Solution 2 mg Dexium™ Tablets Pet Derm® III Tablets Dexamethasone Sodium Phosphate Inj. Dexamethasone Injection Dex-A-Vet Injection Dexameth-A-Vet Injection Dexameth-A-Vet Dexamethasone Sterile Solution Dexachel Dexamethasone Solution Dexium® Dexium-SP™ Dexamethasone Acetate Anhydrous DEXAMETHASONE Dexamethasone SP Dexium DEXASONE Dexium-SP
Dosage forms
Liquid (Solution) Tablet Powder Bolus Liquid Tablet (Chewable) Injectable Solution

Indications / Uses

In treatment of dogs as an anti-inflammatory agent. In treatment of cats as an anti-inflammatory agent. The drug is indicated for the treatment of primary bovine ketosis.

Warnings / Contraindications

Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

  • Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

Side Effects

Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Anaphylaxis, Death, Facial swelling (see also 'Skin').

FAQ

Both, Dog, Horse, Not For Meat Production, Cat, Horse, Dog, Restricted During Pregnancy

Yes. Roxee shows this as prescription-only.

Liquid (Solution), Tablet, Powder, Bolus

Related Conditions

Congestive heart failure Dystocia Lameness (undifferentiated) Metritis

Source Transparency

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy
  • and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis
  • Do not use in viral infections
  • Anti-inflammatory action of corticosteroids may mask signs of infections
  • Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy
  • Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis
  • Not for use in horses intended for food
  • Vomiting (1 reports)
  • wobbly/unsteady walking (1 reports)
  • Loss of appetite (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?

Next actions

Talk to a Vet / Find a Vet Near You Save to pet meds Share page Review report evidence
Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Dexamethasone; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA case USA-USFDACVM-2025-US-068758
Safety signal coverage Reported signals

32 tracked reaction signals; 32 reported cases; 30 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA case USA-USFDACVM-2025-US-068758
Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA case USA-USFDACVM-2025-US-068758
Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Vomiting (1 reports), Unsteady walking (ataxia) (1 reports), Loss of appetite (1 reports), Elevated total bilirubin (1 reports), Elevated temperature (1 reports)

Body systems represented Signal grouping

Digestive (4), Neurologic (1), Behavior (1), Other (26)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Dog (19 reports), Cat (13 reports)

Breed metadata in reports Metadata only

Dachshund - Miniature (2), ['Shepherd Dog - Australian', 'Poodle (unspecified)'] (1), ['Terrier - Jack Russell', 'Terrier - Bull - American Pit'] (1), Retriever - Labrador (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Dexamethasone fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

Clinical and experimental data have demonstrated that corticosteroids administered orally or by inje, and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta,, Do not use in viral infections, Anti-inflammatory action of corticosteroids may mask signs of infections, Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, e

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Dexamethasone brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
  1. openFDA case USA-USFDACVM-2025-US-068758 · adverse_reaction · adverse reactions
  2. Contraindication source · fda_animal_drugs · warnings contraindications
  3. FDA application profile · official_label · quick facts
  4. FDA application profile · official_label · quick facts
  5. Medication usage source · fda_animal_drugs · quick facts
  6. FOI · document · documents
  7. SPL · document · documents
  8. FOI · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: February 12, 2026, 10:44 PM UTC

Sources:
Safety & side effects

Side effects to monitor:

  • Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy
  • and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis
  • Do not use in viral infections
  • Anti-inflammatory action of corticosteroids may mask signs of infections
  • Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy

Most reported reactions:

  • Vomiting (1 reports)
  • Unsteady walking (ataxia) (1 reports)
  • Loss of appetite (1 reports)
Explore reported case details

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species
Cat, Dog, Horse
Indication / use
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.
Form / route / dose
Form: Bolus, Injectable Solution, Liquid, Liquid (Solution), Powder, Tablet, Tablet (Chewable)
Route: Intramuscular, Intravenous, Oral
Confirm product label and patient-specific plan.
Warnings
  • High: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals ma…
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Multiple FDA labelers
Form: Bolus, Injectable Solution, Liquid, Liquid (Solution), Powder, Tablet
Identifiers:
ANADA: 200108 ANADA: 200312 ANADA: 200317 ANADA: 200324 ANADA: 200456 ANADA: 200565 NADA: 104606 NADA: 108687 NADA: 110046 NADA: 110349 NADA: 110350 NADA: 111369 NADA: 11885 NADA: 11901 NADA: 123815 NADA: 12559 NADA: 128089 NADA: 130660 NADA: 141598 NADA: 30136
Source metadata:

Warnings / Contraindications

Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

  • High: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
12
Matching reports
0
Active filters
2
Selected filters
Reaction: Vomiting Clear Body system: Skin & allergy Clear
Reset
Drill into common report signals
Emesis (multiple) (4) Not eating (4) Vomiting (4) Anaphylaxis (3) Other (12) Digestive (8) Skin & allergy (6) Neurologic (4)
No stored openFDA reports match the selected filters. openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
30
Species represented
2
Grouped by Body System
Digestive (4) · Vomiting, Loss of appetite, Diarrhea Neurologic (1) · Unsteady walking (ataxia) Behavior (1) · Biting -aggression Other (26) · Elevated total bilirubin, Elevated temperature, Elevated serum alkaline phosphatase
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Digestive 1 Cat 1
Neurologic 1 Dog 1
Digestive 1 Dog 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Cat 1

Species coverage: Dog (19) Cat (13)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Digestive Cat Serious - 1
Neurologic Dog Serious - 1
Digestive Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Digestive Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Digestive Cat Non-serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Behavior Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Non-serious - 1
Other Dog Serious - 1
Source metadata:

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

Dexium-SP™ SPL · SPL Dexamethasone Solution SPL · SPL Zonometh Solution SPL · SPL

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

34

FOI

7

Dexium-SP™

SPL · SPL

Open original
FDA Structured Product Label

Dexium-SP™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Bimeda Animal Health Ltd.
ANADA
200-317
Status
RX
Form
Injectable Solution
Route
Intravenous
Composition / specifications
Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).

Horses

Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexamethasone Solution

SPL · SPL

Open original
FDA Structured Product Label

Dexamethasone Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Med-Pharmex, Inc.
ANADA
200-456
Status
RX
Form
Injectable Solution
Route
Intravenous, Intramuscular
Composition / specifications
Each milliliter of solution contains 2 milligrams dexamethasone.

Cattle

Indication
For the treatment of primary bovine ketosis and as an anti-inflammatory agent.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
For use as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Zonometh Solution

SPL · SPL

Open original
FDA Structured Product Label

Zonometh Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Huvepharma EOOD
NADA
128-089
Status
RX
Form
Liquid (Solution)
Route
Intravenous, Intramuscular
Species
Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone

Dogs

Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
The drug is used as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexameth-A-Vet

SPL · SPL

Open original
FDA Structured Product Label

Dexameth-A-Vet

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Bimeda Animal Health Ltd.
NADA
99607
Status
RX
Form
Liquid (Solution)
Route
Intravenous
Species
Horse
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains either 2.0 milligrams of dexamethasone or 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).

Horses

Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexameth-A-Vet Injection

SPL · SPL

Open original
FDA Structured Product Label

Dexameth-A-Vet Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Bimeda Animal Health Ltd.
NADA
99606
Status
RX
Form
Liquid (Solution)
Route
Intravenous
Species
Dog
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains either 2.0 milligrams of dexamethasone or 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).

Dogs

Indication
The drug is used in dogs for the treatment of inflammatory conditions, as supportive therapy in canine posterior paresis, as supportive therapy before or after surgery to enhance recovery of poor surgical risks, and as supportive therapy in nonspecific dermatosis.
Dosage
The drug is administered intravenously at 0.25 to 1 milligram initially. The dose may be repeated for 3 to 5 days or until a response is noted. If continued treatment is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dex-A-Vet Injection

SPL · SPL

Open original
FDA Structured Product Label

Dex-A-Vet Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Bimeda Animal Health Ltd.
NADA
99604
Status
RX
Form
Liquid (Solution)
Route
Intravenous
Species
Horse
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).

Horses

Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dex-A-Vet Injection

SPL · SPL

Open original
FDA Structured Product Label

Dex-A-Vet Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Bimeda Animal Health Ltd.
NADA
99605
Status
RX
Form
Liquid (Solution)
Route
Intravenous
Species
Dog
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).

Dogs

Indication
The drug is used in dogs for the treatment of inflammatory conditions, as supportive therapy in canine posterior paresis, as supportive therapy before or after surgery to enhance recovery of poor surgical risks, and as supportive therapy in nonspecific dermatosis.
Dosage
The drug is administered intravenously at 0.25 to 1 milligram initially. The dose may be repeated for 3 to 5 days or until a response is noted. If continued treatment is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexium®

SPL · SPL

Open original
FDA Structured Product Label

Dexium®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Bimeda Animal Health Ltd.
ANADA
200-312
Status
RX
Form
Liquid (Solution)
Route
Intramuscular, Intravenous
Species
Dog • Horse • Cat
Composition / specifications
Each milliliter contains 2 milligrams of dexamethasone.

Horses

Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

Cattle

Indication
The drug is indicated as an anti-inflammatory agent in cattle.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
The drug is indicated as an anti-inflammatory agent in cats.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dogs

Indication
The drug is indicated as an anti-inflammatory agent in dogs.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexium™ Tablets

SPL · SPL

Open original
FDA Structured Product Label

Dexium™ Tablets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Bimeda Animal Health Ltd.
NADA
95218
Status
RX
Form
Tablet
Route
Oral
Species
Dog • Cat
Composition / specifications
Each tablet contains 0.25 milligram of dexamethasone.

Cats

Indication
Dexamethasone is indicated for use as an anti-inflammatory agent
Dosage
Administer orally at 0.125 to 0.5 mg. per day up to 7 days
Limitations
Do not use in viral infections. Except for emergency therapy, do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome and peptic ulcers. Existence of congestive heart failure, diabetes and osteoporosis are relative contraindications. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in cleft palate in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies including deformed forelegs, phocomelia and anasarca.

Dogs

Indication
Dexamethasone is indicated for use as an anti-inflammatory agent
Dosage
Administer orally at 0.25 to 1.25 mg. per day up to 7 days
Limitations
Do not use in viral infections. Except for emergency therapy, do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome and peptic ulcers. Existence of congestive heart failure, diabetes and osteoporosis are relative contraindications. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in cleft palate in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies including deformed forelegs, phocomelia and anasarca.

Dexamethasone Injection

SPL · SPL

Open original
FDA Structured Product Label

Dexamethasone Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Watson Laboratories, Inc.
NADA
104-606
Status
RX
Form
Liquid (Solution)
Route
Intravenous
Species
Dog • Horse
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).

Dogs

Indication
The drug is used in dogs for the treatment of inflammatory conditions, as supportive therapy in canine posterior paresis as supportive therapy before or after surgery to enhance recovery of poor surgical risks, and as supportive therapy in nonspecific dermatosis.
Dosage
The drug is administered intravenously at 0.25 to 1 milligram initially. The dose may be repeated for 3 to 5 days or until a response is noted. If continued treatment is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexamethasone Solution

SPL · SPL

Open original
FDA Structured Product Label

Dexamethasone Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Huvepharma EOOD
ANADA
200-108
Status
RX
Form
Liquid (Solution)
Route
Intravenous, Intramuscular
Species
Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.

Cats

Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dogs

Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
0.25 to 1 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cattle

Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
5 to 20 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexamethasone Sterile Solution

SPL · SPL

Open original
FDA Structured Product Label

Dexamethasone Sterile Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Kinetic Technologies, LLC
NADA
111-369
Status
RX
Form
Liquid (Solution)
Route
Intravenous, Intramuscular
Species
Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone

Dogs

Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.25 to 1 milligram administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
The drug is used as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Pet Derm® III Tablets

SPL · SPL

Open original
FDA Structured Product Label

Pet Derm® III Tablets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Kinetic Technologies, LLC
NADA
108-687
Status
RX
Form
Tablet (Chewable)
Route
Oral
Species
Dog
Composition / specifications
Each half-scored tablet contains 0.25 milligrams of dexamethasone.

Dogs

Indication
Supportive therapy in nonspecific dermatosis and inflammatory conditions.
Dosage
0.25 to 1.25 milligrams per day. Administer by free-choice feeding or crumble over food. Administer 0.25 to 1.25 milligrams daily in single or two divided doses until response is noted or 7 days have elapsed. When response is attained, dosage should be gradually reduced by 0.125 milligram per day until maintenance level is achieved.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy, and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infection. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Azium® Aqueous Suspension Veterinary

SPL · SPL

Open original
FDA Structured Product Label

Azium® Aqueous Suspension Veterinary

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
11901
Status
RX
Form
Liquid (Solution)
Route
Intramuscular, Intravenous
Species
Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.

Cattle

Indication
The drug is indicated for the treatment of primary bovine ketosis.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

Cats

Indication
The drug is indicated as an anti-inflammatory agent in cats.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dogs

Indication
The drug is indicated as an anti-inflammatory agent in dogs.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Azium® Boluses 10 mg

SPL · SPL

Open original
FDA Structured Product Label

Azium® Boluses 10 mg

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
30435
Status
RX
Form
Bolus
Route
Oral
Species
Horse
Composition / specifications
Each bolus is half-scored and contains 10 milligrams of dexamethasone.

Cattle

Indication
Dexamethasone bolus is indicated in cases where cattle require additional steroid therapy following its parenteral administration. The drug may be used as supportive therapy for management of inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
Administered orally, 5 to 10 milligrams for the first day, then 5 milligrams per day as required.
Limitations
Do not use in viral infections during the viremic stage. With bacterial infections, appropriate antibacterial therapy should be used. Do not use in animals with chronic nephritis and hypercorticalism (cushingoid syndrome) except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

Horses

Indication
Dexamethasone bolus is indicated in cases where horses require additional steroid therapy following its parenteral administration. The drug may be used as supportive therapy for management of inflammatory conditions such as acute arthritic lameness es; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
Administered orally, 5 to 10 milligrams for the first day, then 5 milligrams per day as required.
Limitations
Do not use in viral infections during the viremic stage. With bacterial infections, appropriate antibacterial therapy should be used. Do not use in animals with chronic nephritis and hypercorticalism (cushingoid syndrome) except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Azium® Oral Solution 2 mg

SPL · SPL

Open original
FDA Structured Product Label

Azium® Oral Solution 2 mg

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
92835
Status
RX
Form
Liquid
Route
Oral
Species
Dog • Horse • Cat

Azium® Powder

SPL · SPL

Open original
FDA Structured Product Label

Azium® Powder

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
30434
Status
RX
Form
Powder
Route
Oral
Species
Horse
Composition / specifications
Dexamethasone powder is packaged in packets containing 10 milligrams of dexamethasone.

Cattle

Indication
Dexamethasone powder is indicated in cases where cattle require additional steroid therapy following its parenteral administration. The drug is used as supportive therapy for management or inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
The drug is administered at a dosage level of 5 to 10 milligrams per animal the first day then 5 milligrams per day as required by drench or by sprinkling on a small amount of feed.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

Horses

Indication
Dexamethasone powder is indicated in cases where horses require additional steroid therapy following its parenteral administration. The drug is used as supportive therapy for management or inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
The drug is administered at a dosage level of 5 to 10 milligrams per animal the first day then 5 milligrams per day as required by drench or by sprinkling on a small amount of feed.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Azium® Solution

SPL · SPL

Open original
FDA Structured Product Label

Azium® Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
12559
Status
RX
Form
Liquid (Solution)
Route
Intramuscular, Intravenous
Species
Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.

Dogs

Indication
The drug is indicated as an anti-inflammatory agent in dogs.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
The drug is indicated as an anti-inflammatory agent in cats.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cattle

Indication
The drug is indicated as an anti-inflammatory agent in cattle.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

Azium® Tablets 0.25 mg

SPL · SPL

Open original
FDA Structured Product Label

Azium® Tablets 0.25 mg

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
11885
Status
RX
Form
Tablet
Route
Oral
Species
Dog • Cat
Composition / specifications
Each tablet contains 0.25 milligram of dexamethasone.

Dogs

Indication
In treatment of dogs as an anti-inflammatory agent.
Dosage
Administer orally at 0.25 to 1.25 milligrams per day for up to 7 days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
In treatment of cats as an anti-inflammatory agent.
Dosage
Administer orally at 0.125 to 0.5 milligram per day for up to 7 days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexachel

SPL · SPL

Open original
FDA Structured Product Label

Dexachel

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Zoetis Inc.
NADA
130-660
Status
RX
Form
Liquid (Solution)
Route
Intravenous
Species
Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone

Dogs

Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.25 to 1 milligrams administered intravenously.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams administered intravenously.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
The drug is used as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexamethasone Injection

SPL · SPL

Open original

This source does not expose a safe inline preview. Use the original source link for the full document.

Dexamethasone Injection

SPL · SPL

Open original

This source does not expose a safe inline preview. Use the original source link for the full document.

Dexamethasone Injection

SPL · SPL

Open original
FDA Structured Product Label

Dexamethasone Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Sparhawk Laboratories, Inc.
ANADA
200-324
Status
RX
Form
Liquid (Solution)
Route
Intravenous, Intramuscular
Species
Horse
Composition / specifications
Each milliliter contains 2 milligrams of dexamethasone.

Cattle

Indication
For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dexamethasone Sodium Phosphate Inj.

SPL · SPL

Open original

This source does not expose a safe inline preview. Use the original source link for the full document.

Dexamethasone Sodium Phosphate Inj.

SPL · SPL

Open original
FDA Structured Product Label

Dexamethasone Sodium Phosphate Inj.

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Cronus Pharma Specialities India Private Ltd.
NADA
123-815
Status
RX
Form
Liquid (Solution)
Route
Intravenous
Species
Dog • Horse
Composition / specifications
Specifications: The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).

Dogs

Indication
The drug is given for glucocorticoid and anti-inflammatory agent.
Dosage
0.25 to 1 milligram initially, administered intravenously. May be repeated for 3 to 5 days or until response is noted.
Limitations
If permanent glucocorticoid effect is required, oral therapy may be substituted. When therapy is to be withdraw after prolonged use, the daily dose should be reduced gradually over several days. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of glucocorticoids may mask signs of infection. Except when used for emergency therapy, the product is contraindicated in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
The drug is given for glucocorticoid and anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously.
Limitations
If permanent glucocorticoid effect is required, oral therapy may be substituted. When therapy is to be withdraw after prolonged use, the daily dose should be reduced gradually over several days. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of glucocorticoids may mask signs of infection. Except when used for emergency therapy, the product is contraindicated in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

DEXAMETHASONE SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for DEXAMETHASONE. Use the source link for the full official labeling record.

DEXAMETHASONE SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for DEXAMETHASONE. Use the source link for the full official labeling record.

DEXAMETHASONE SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for DEXAMETHASONE. Use the source link for the full official labeling record.

DEXASONE SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for DEXASONE. Use the source link for the full official labeling record.

Dexium-SP SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Dexium-SP. Use the source link for the full official labeling record.

DEXAMETHASONE SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for DEXAMETHASONE. Use the source link for the full official labeling record.

Dexium SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Dexium. Use the source link for the full official labeling record.

Dexamethasone SP SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Dexamethasone SP. Use the source link for the full official labeling record.

Dexamethasone Acetate Anhydrous SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Dexamethasone Acetate Anhydrous. Use the source link for the full official labeling record.

ucm061771.pdf

FOI · FOI

Open original

UCM492475.pdf

FOI · FOI

Open original

ucm061765.pdf

FOI · FOI

Open original

A200108_Org_4_13_1995.pdf

FOI · FOI

Open original

ucm061789.pdf

FOI · FOI

Open original

FOI Summary oN 141-598 Approved April 10 2025_ceg_ef.pdf

FOI · FOI summary

Open original

UCM457231.pdf

FOI · FOI summary

Open original
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Reference facts: Source Roxee | Refreshed Jun 22, 2026, 10:41 AM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Jun 22, 2026, 10:40 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Jun 22, 2026, 10:41 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: DEXAMETHASONE DEXASONE Dexamethasone Acetate Anhydrous Dexamethasone SP Dexium Dexium-SP
Manufacturer mapping: Multiple FDA labelers
Case-reported brands (openFDA): MSK
Catalog species: Both • FDA-labeled species: Cat, Dog, Horse
Rx/OTC: RX
Form/route: Bolus, Injectable Solution, Liquid, Liquid (Solution), Powder, Tablet, Tablet (Chewable) • Intramuscular, Intravenous, Oral
Applications: ANADA 200-317 • ANADA 200-456 • NADA 128-089 • NADA 99607 • NADA 99606 • NADA 99604 • NADA 99605 • ANADA 200-312 • NADA 95218 • NADA 104-606 • ANADA 200-108 • NADA 111-369 • NADA 108-687 • NADA 11901 • NADA 30435 • NADA 92835 • NADA 30434 • NADA 12559 • NADA 11885 • NADA 130-660 • NADA 110-349 • NADA 110-350 • ANADA 200-324 • NADA 110-046 • NADA 123-815
NDC: Packages 13985-043-29 13985-533-03 13985-533-25 46066-223-04 46066-223-80 50989-437-12 • Products 13985 46066 50989 57319 60270 61133
Documents: 5 (FOI: 5) • SPL: 25 • Label highlights • Official documents
Safety (openFDA)
Top reactions: Dog 56 • Cat 21 • View
Case summaries: 12 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Explore
Linked using: Fda_Label (0.95), Fda_Label (0.95), Fda_Label (0.95)
Diagnosis Codes
ICD10_CM: H60.90
Otitis externa, unspecified ear

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food. (Contraindication, High)
Top reaction signals
Vomiting (1) Unsteady walking (ataxia) (1) Loss of appetite (1) Elevated total bilirubin (1) Elevated temperature (1) Elevated serum alkaline phosphatase (1) Elevated renal parameters (1) Elevated gamma-glutamyl transferase (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
ANADA: 200108 ANADA: 200312 ANADA: 200317 ANADA: 200324 ANADA: 200456 ANADA: 200565 NADA: 104606 NADA: 108687 NADA: 110046 NADA: 110349 NADA: 110350 NADA: 111369 NADA: 11885 NADA: 11901 NADA: 123815 NADA: 12559 NADA: 128089 NADA: 130660 NADA: 141598 NADA: 30136 NADA: 30434 NADA: 30435 NADA: 42633 NADA: 92835
Package NDC Product NDC Form / Route Status
0010-5587-01 0010 -
0010-5587-02 0010 -
0010-5587-03 0010 -
0010-5587-04 0010 -
13985-043-29 13985 -
13985-533-03 13985 -
13985-533-25 13985 -
46066-223-04 46066 -
46066-223-80 46066 -
50989-437-12 50989 -
57319-519-05 57319 -
60270-337-10 60270 -
61133-0892-9 61133 -
61133-0899-9 61133 -
73309-154-01 73309 -
73309-154-02 73309 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • DEXAMETHASONE SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • DEXAMETHASONE SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • DEXAMETHASONE SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • DEXASONE SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Dexium-SP SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • DEXAMETHASONE SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Dexium SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Dexamethasone SP SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Dexamethasone Acetate Anhydrous SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • FOI Summary oN 141-598 Approved April 10 2025_ceg_ef.pdf • FOI summary • Official • June 3, 2025
    FDA FOI summary for application 141598
  • ucm061771.pdf • FOI summary • Official • April 1, 2024
    FDA FOI summary for application 200317
  • UCM492475.pdf • FOI summary • Official • Dec. 26, 2023
    FDA FOI summary for application 200456
  • ucm061765.pdf • FOI summary • Official • Oct. 2, 2018
    FDA FOI summary for application 200312
  • A200108_Org_4_13_1995.pdf • FOI summary • Official • May 16, 2017
    FDA FOI summary for application 200108
  • ucm061789.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200324
  • UCM457231.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200565

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 135 Clinical 1 Manufacturer 0 Marketing 0
Current Field Facts
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Anaphylaxis, Death, Facial swel… (Clinical, 2026-04-11)
  • contraindications: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition … (Official, 2026-04-12)
  • contraindications: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition … (Official, 2026-04-11)
  • contraindications: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition … (Official, 2026-02-12)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-22)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-22)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-21)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-20)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-13)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-12)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-12)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-11)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-11)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-10)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-09)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-08)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-07)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-06)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-05)
  • indications: For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses. (Official, 2026-06-04)
Recent Revisions
  • side_effects updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Dexium-SP™
RX
Dexamethasone Sodium Phosphate
Injectable Solution • Intravenous
Label highlights
Official documents
Bimeda Animal Health Ltd. ANADA 200-317 Approved Apr 1, 2024
Dexamethasone Solution
RX
Dexamethasone
Injectable Solution • Intravenous, Intramuscular
Label highlights
Official documents
Med-Pharmex, Inc. ANADA 200-456 W Dec 26, 2023
Zonometh Solution
RX
Dexamethasone
Liquid (Solution) • Intravenous, Intramuscular
Label highlights
Official documents
Huvepharma EOOD NADA 128-089 Approved Aug 7, 2019
Dexameth-A-Vet
RX
Dexamethasone
Liquid (Solution) • Intravenous
Label highlights
Official documents
Bimeda Animal Health Ltd. NADA 99607 Approved Oct 2, 2018
Dexameth-A-Vet Injection
RX
Dexamethasone
Liquid (Solution) • Intravenous
Label highlights
Official documents
Bimeda Animal Health Ltd. NADA 99606 Approved Oct 2, 2018
Dex-A-Vet Injection
RX
Dexamethasone Sodium Phosphate
Liquid (Solution) • Intravenous
Label highlights
Official documents
Bimeda Animal Health Ltd. NADA 99604 Approved Oct 2, 2018
Dex-A-Vet Injection
RX
Dexamethasone Sodium Phosphate
Liquid (Solution) • Intravenous
Label highlights
Official documents
Bimeda Animal Health Ltd. NADA 99605 Approved Oct 2, 2018
Dexium®
RX
Dexamethasone
Liquid (Solution) • Intramuscular, Intravenous
Label highlights
Official documents
Bimeda Animal Health Ltd. ANADA 200-312 Approved Oct 2, 2018
Dexium™ Tablets
RX
Dexamethasone
Tablet • Oral
Label highlights
Official documents
Bimeda Animal Health Ltd. NADA 95218 Approved Oct 2, 2018
Dexamethasone Injection
RX
Dexamethasone Sodium Phosphate
Liquid (Solution) • Intravenous
Label highlights
Official documents
Watson Laboratories, Inc. NADA 104-606 W Jul 25, 2018
Dexamethasone Solution
RX
Dexamethasone
Liquid (Solution) • Intravenous, Intramuscular
Label highlights
Official documents
Huvepharma EOOD ANADA 200-108 Approved May 16, 2017
Dexamethasone Sterile Solution
RX
Dexamethasone
Liquid (Solution) • Intravenous, Intramuscular
Label highlights
Official documents
Kinetic Technologies, LLC NADA 111-369 Approved Nov 3, 2016
Pet Derm® III Tablets
RX
Dexamethasone
Tablet (Chewable) • Oral
Label highlights
Official documents
Kinetic Technologies, LLC NADA 108-687 Approved Nov 3, 2016
Azium® Aqueous Suspension Veterinary
RX
Dexamethasone
Liquid (Solution) • Intramuscular, Intravenous
Label highlights
Official documents
Intervet, Inc. NADA 11901 Approved Jun 1, 2016
Azium® Boluses 10 mg
RX
Dexamethasone
Bolus • Oral
Label highlights
Official documents
Intervet, Inc. NADA 30435 Approved Jun 1, 2016
Azium® Oral Solution 2 mg
RX
Dexamethasone
Liquid • Oral
Official documents
Intervet, Inc. NADA 92835 Approved Jun 1, 2016
Azium® Powder
RX
Dexamethasone
Powder • Oral
Label highlights
Official documents
Intervet, Inc. NADA 30434 Approved Jun 1, 2016
Azium® Solution
RX
Dexamethasone
Liquid (Solution) • Intramuscular, Intravenous
Label highlights
Official documents
Intervet, Inc. NADA 12559 Approved Jun 1, 2016
Azium® Tablets 0.25 mg
RX
Dexamethasone
Tablet • Oral
Label highlights
Official documents
Intervet, Inc. NADA 11885 Approved Jun 1, 2016
Dexachel
RX
Dexamethasone
Liquid (Solution) • Intravenous
Label highlights
Official documents
Zoetis Inc. NADA 130-660 Approved Jun 1, 2016
Dexamethasone Injection
RX
Dexamethasone Sodium Phosphate
Official documents
Watson Laboratories, Inc. NADA 110-349 W Jun 1, 2016
Dexamethasone Injection
RX
Dexamethasone
Official documents
Watson Laboratories, Inc. NADA 110-350 W Jun 1, 2016
Dexamethasone Injection
RX
Dexamethasone
Liquid (Solution) • Intravenous, Intramuscular
Label highlights
Official documents
Sparhawk Laboratories, Inc. ANADA 200-324 Approved Jun 1, 2016
Dexamethasone Sodium Phosphate Inj.
RX
Dexamethasone Sodium Phosphate
Official documents
Akorn, Inc. NADA 110-046 W Jun 1, 2016
Dexamethasone Sodium Phosphate Inj.
RX
Dexamethasone Sodium Phosphate
Liquid (Solution) • Intravenous
Label highlights
Official documents
Cronus Pharma Specialities India Private Ltd. NADA 123-815 Approved Jun 1, 2016

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Composition / specifications
Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).
Horses
Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Composition / specifications
Each milliliter of solution contains 2 milligrams dexamethasone.
Cattle
Indication
For the treatment of primary bovine ketosis and as an anti-inflammatory agent.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
For use as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone
Dogs
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is used as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Horse
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains either 2.0 milligrams of dexamethasone or 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).
Horses
Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains either 2.0 milligrams of dexamethasone or 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).
Dogs
Indication
The drug is used in dogs for the treatment of inflammatory conditions, as supportive therapy in canine posterior paresis, as supportive therapy before or after surgery to enhance recovery of poor surgical risks, and as supportive therapy in nonspecific dermatosis.
Dosage
The drug is administered intravenously at 0.25 to 1 milligram initially. The dose may be repeated for 3 to 5 days or until a response is noted. If continued treatment is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Horse
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).
Horses
Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).
Dogs
Indication
The drug is used in dogs for the treatment of inflammatory conditions, as supportive therapy in canine posterior paresis, as supportive therapy before or after surgery to enhance recovery of poor surgical risks, and as supportive therapy in nonspecific dermatosis.
Dosage
The drug is administered intravenously at 0.25 to 1 milligram initially. The dose may be repeated for 3 to 5 days or until a response is noted. If continued treatment is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse • Cat
Composition / specifications
Each milliliter contains 2 milligrams of dexamethasone.
Horses
Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.
Cattle
Indication
The drug is indicated as an anti-inflammatory agent in cattle.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is indicated as an anti-inflammatory agent in cats.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
The drug is indicated as an anti-inflammatory agent in dogs.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Cat
Composition / specifications
Each tablet contains 0.25 milligram of dexamethasone.
Cats
Indication
Dexamethasone is indicated for use as an anti-inflammatory agent
Dosage
Administer orally at 0.125 to 0.5 mg. per day up to 7 days
Limitations
Do not use in viral infections. Except for emergency therapy, do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome and peptic ulcers. Existence of congestive heart failure, diabetes and osteoporosis are relative contraindications. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in cleft palate in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies including deformed forelegs, phocomelia and anasarca.
Dogs
Indication
Dexamethasone is indicated for use as an anti-inflammatory agent
Dosage
Administer orally at 0.25 to 1.25 mg. per day up to 7 days
Limitations
Do not use in viral infections. Except for emergency therapy, do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome and peptic ulcers. Existence of congestive heart failure, diabetes and osteoporosis are relative contraindications. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in cleft palate in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies including deformed forelegs, phocomelia and anasarca.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).
Dogs
Indication
The drug is used in dogs for the treatment of inflammatory conditions, as supportive therapy in canine posterior paresis as supportive therapy before or after surgery to enhance recovery of poor surgical risks, and as supportive therapy in nonspecific dermatosis.
Dosage
The drug is administered intravenously at 0.25 to 1 milligram initially. The dose may be repeated for 3 to 5 days or until a response is noted. If continued treatment is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.
Cats
Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
0.25 to 1 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cattle
Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
5 to 20 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone
Dogs
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.25 to 1 milligram administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is used as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog
Composition / specifications
Each half-scored tablet contains 0.25 milligrams of dexamethasone.
Dogs
Indication
Supportive therapy in nonspecific dermatosis and inflammatory conditions.
Dosage
0.25 to 1.25 milligrams per day. Administer by free-choice feeding or crumble over food. Administer 0.25 to 1.25 milligrams daily in single or two divided doses until response is noted or 7 days have elapsed. When response is attained, dosage should be gradually reduced by 0.125 milligram per day until maintenance level is achieved.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy, and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infection. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.
Cattle
Indication
The drug is indicated for the treatment of primary bovine ketosis.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.
Cats
Indication
The drug is indicated as an anti-inflammatory agent in cats.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
The drug is indicated as an anti-inflammatory agent in dogs.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Horse
Composition / specifications
Each bolus is half-scored and contains 10 milligrams of dexamethasone.
Cattle
Indication
Dexamethasone bolus is indicated in cases where cattle require additional steroid therapy following its parenteral administration. The drug may be used as supportive therapy for management of inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
Administered orally, 5 to 10 milligrams for the first day, then 5 milligrams per day as required.
Limitations
Do not use in viral infections during the viremic stage. With bacterial infections, appropriate antibacterial therapy should be used. Do not use in animals with chronic nephritis and hypercorticalism (cushingoid syndrome) except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
Horses
Indication
Dexamethasone bolus is indicated in cases where horses require additional steroid therapy following its parenteral administration. The drug may be used as supportive therapy for management of inflammatory conditions such as acute arthritic lameness es; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
Administered orally, 5 to 10 milligrams for the first day, then 5 milligrams per day as required.
Limitations
Do not use in viral infections during the viremic stage. With bacterial infections, appropriate antibacterial therapy should be used. Do not use in animals with chronic nephritis and hypercorticalism (cushingoid syndrome) except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Horse
Composition / specifications
Dexamethasone powder is packaged in packets containing 10 milligrams of dexamethasone.
Cattle
Indication
Dexamethasone powder is indicated in cases where cattle require additional steroid therapy following its parenteral administration. The drug is used as supportive therapy for management or inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
The drug is administered at a dosage level of 5 to 10 milligrams per animal the first day then 5 milligrams per day as required by drench or by sprinkling on a small amount of feed.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
Horses
Indication
Dexamethasone powder is indicated in cases where horses require additional steroid therapy following its parenteral administration. The drug is used as supportive therapy for management or inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
The drug is administered at a dosage level of 5 to 10 milligrams per animal the first day then 5 milligrams per day as required by drench or by sprinkling on a small amount of feed.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.
Dogs
Indication
The drug is indicated as an anti-inflammatory agent in dogs.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is indicated as an anti-inflammatory agent in cats.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cattle
Indication
The drug is indicated as an anti-inflammatory agent in cattle.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Cat
Composition / specifications
Each tablet contains 0.25 milligram of dexamethasone.
Dogs
Indication
In treatment of dogs as an anti-inflammatory agent.
Dosage
Administer orally at 0.25 to 1.25 milligrams per day for up to 7 days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
In treatment of cats as an anti-inflammatory agent.
Dosage
Administer orally at 0.125 to 0.5 milligram per day for up to 7 days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse • Cat
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone
Dogs
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.25 to 1 milligrams administered intravenously.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams administered intravenously.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is used as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Horse
Composition / specifications
Each milliliter contains 2 milligrams of dexamethasone.
Cattle
Indication
For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse
Composition / specifications
Specifications: The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).
Dogs
Indication
The drug is given for glucocorticoid and anti-inflammatory agent.
Dosage
0.25 to 1 milligram initially, administered intravenously. May be repeated for 3 to 5 days or until response is noted.
Limitations
If permanent glucocorticoid effect is required, oral therapy may be substituted. When therapy is to be withdraw after prolonged use, the daily dose should be reduced gradually over several days. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of glucocorticoids may mask signs of infection. Except when used for emergency therapy, the product is contraindicated in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is given for glucocorticoid and anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously.
Limitations
If permanent glucocorticoid effect is required, oral therapy may be substituted. When therapy is to be withdraw after prolonged use, the daily dose should be reduced gradually over several days. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of glucocorticoids may mask signs of infection. Except when used for emergency therapy, the product is contraindicated in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Usage

In treatment of dogs as an anti-inflammatory agent. In treatment of cats as an anti-inflammatory agent. The drug is indicated for the treatment of primary bovine ketosis.

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Vomiting (1) • Cat Loss of appetite (1) • Dog Diarrhea (1) • Dog Decreased appetite (1) • Cat

Showing top 5 for Digestive.

Neurologic
Unsteady walking (1) • Dog

Showing top 5 for Neurologic.

Behavior
Biting -aggression (1) • Dog

Showing top 5 for Behavior.

Other
Elevated total bilirubin (1) • Dog Elevated temperature (1) • Cat Elevated serum alkaline phosphatase (1) • Dog Elevated renal parameters (1) • Cat Elevated gamma-glutamyl transferase (1) • Cat
Show more (21)
Elevated blood urea nitrogen (1) • Dog Elevated alanine aminotransferase (1) • Dog Dry mucous membrane (1) • Cat Diabetic ketoacidosis (1) • Cat Diabetes mellitus (1) • Cat Dermatitis (1) • Dog Dehydration (1) • Dog Decreased blood urea nitrogen (BUN) or creatinine (1) • Dog Death (1) • Dog Deafness (1) • Cat Constricted pupils (1) • Dog Circulatory collapse (1) • Dog Blood in urine (1) • Dog Azotaemia (1) • Cat Anaphylaxis (1) • Cat Anal sac disorder (1) • Dog Anaemia NOS (1) • Dog Agglutination test, positive (1) • Dog Abnormal ultrasound finding (1) • Cat Abnormal radiograph finding (1) • Cat Abnormal cytology (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, ['Shepherd Dog - Australian', 'Poodle (unspecified)'], Male, 2 year, 24.131 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Polyuria, Soft stool, Vomiting • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-075387
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 2.00 Year
  • Weight: 24.131 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Polyuria Soft stool Vomiting
Outcomes: Ongoing

Dog, ['Terrier - Jack Russell', 'Terrier - Bull - American Pit'], Female, 1 year, 17.236 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Vomiting, Hives, Reddening of the skin, Skin irritation, Urine leakage… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-074361
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 1.00 Year
  • Weight: 17.236 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Vomiting Hives Reddening of the skin Skin irritation Urine leakage Hypersensitivity reaction
Outcomes: Ongoing

Dog, Retriever - Labrador, Female, 8 year, 33.339 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Immune mediated haemolytic anaemia, Death, Anaemia NOS, Thrombocytopenia, Neutrophilia… • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-074459
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 8.00 Year
  • Weight: 33.339 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Immune mediated haemolytic anaemia Death Anaemia NOS Thrombocytopenia Neutrophilia Heart murmur Vomiting Icterus Panting Not eating Other abnormal test result NOS Elevated alanine aminotransferase Elevated total bilirubin Elevated serum alkaline phosphatase Thrombocytosis Haemolysis NOS Medication error NOS Monocytosis Large platelets Spherocytosis Agglutination test, positive
Outcomes: Died

Dog, Shih Tzu, Female, 11.68 year, 6.53 kilogram • Drug: MSK, Parenteral • Reactions: Not eating, Periorbital oedema, Fever, Local swelling, Nasal discharge… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-074693
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 11.68 Year
  • Weight: 6.530 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Parenteral
Reactions Reported:
Not eating Periorbital oedema Fever Local swelling Nasal discharge Stridor Face and neck swelling Sneezing Respiratory tract disorder NOS Biting -aggression
Outcomes: Ongoing

Dog, Dachshund - Miniature, Female, 1 year, 2.812 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Circulatory collapse, Pale mucous membrane, Vomiting, Hives, Anaphylaxis • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-074149
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 1.00 Year
  • Weight: 2.812 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Circulatory collapse Pale mucous membrane Vomiting Hives Anaphylaxis
Outcomes: Ongoing

Cat, Domestic Shorthair, Male, 5 year, 4.536 kilogram • Drug: MSK, Unknown • Reactions: Limping, Weight loss, Paralysis NOS • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-073798
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Male
  • Age: 5.00 Year
  • Weight: 4.536 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Limping Weight loss Paralysis NOS
Outcomes: Outcome Unknown

Cat, Maine Coon, Male, 8 year, 5.942 kilogram • Drug: MSK, Injection, solution, Unknown • Reactions: Pain NOS, Lameness, Not eating, Fever, High pancreatic-specific lipase… • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2025-US-071120
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Male
  • Age: 8.00 Year
  • Weight: 5.942 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Injection, solution
Reactions Reported:
Pain NOS Lameness Not eating Fever High pancreatic-specific lipase Tiredness (lethargy) Vomiting Lack of efficacy - NOS
Outcomes: Recovered/Normal

Dog, Dachshund - Miniature, Female, 4 year, 5.557 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Vomiting, Lateral recumbency, Pale mucous membrane, Dry mucous membrane, Anaphylaxis… • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2025-US-070459
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 4.00 Year
  • Weight: 5.557 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Vomiting Lateral recumbency Pale mucous membrane Dry mucous membrane Anaphylaxis Hives Swollen muzzle
Outcomes: Recovered/Normal

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.